UNCLASSIFIED//

ROUTINE

R 171847Z NOV 20 MID200000387405U

FM SECNAV WASHINGTON DC

TO ALNAV

INFO SECNAV WASHINGTON DC
CNO WASHINGTON DC
CMC WASHINGTON DC

BT
UNCLAS

ALNAV 096/20

MSGID/GENADMIN/SECNAV WASHINGTON DC/-/NOV//

SUBJ/NAVY MEDICINE COVID-19 RETURN TO FLIGHT DUTY STATUS GUIDELINE POLICY IN 
RESPONSE TO THE CORONAVIRUS DISEASE 2019//

REF/A/DOC/CNAF/05MAY16//
REF/B/DOC/BUMED/15FEB19//
REF/C/DOC/NAMI ARWG/NMOTC/27APR20//

NARR/REF A IS THE CNAF M-3710, NATOPS GENERAL FLIGHT AND OPERATING 
INSTRUCTIONS MANUAL, CHAPTER 8 AEROMEDICAL AND SURVIVAL. 
REF B IS THE NAVMED P-117, MANUAL OF THE MEDICAL DEPARTMENT, CHAPTER 15 
MEDICAL EXAMINATIONS. 
REF C IS THE NAVAL AEROSPACE MEDICAL INSTITUTE, AEROMEDICAL REFERENCE AND 
WAIVER GUIDE.//

RMKS/1.  This ALNAV announces Navy Medicine's COVID-19 Return to Flight Duty 
Status Guideline in response to the Coronavirus Disease 2019 (COVID-19).  
This policy applies to all Navy and Marine Corps personnel requiring a Class 
1 or Class 2 Special Duty Medical Examination for flight duty status as 
required in reference (a) and defined in reference (b).  Naval aircrew who 
have been exposed to COVID-19, tested positive for COVID-19, or infected with 
COVID-19 will require a defined evaluation, per reference (c), to return to 
flight duty status.  The Navy Medicine COVID-19 Return to Flight Duty Status 
Guideline is contained in reference (c), Respiratory section: 
https://www.med.navy.mil/sites /nmotc/nami/arwg/pages/ 
aeromedicalreferenceandwaiverguide.aspx.

2. To support the medical readiness of the armed forces, Navy Medicine 
Readiness and Training Command, Commanders and Commanding Officers, and Navy 
Medicine Readiness and Training Unit Officers-in-Charge shall provide for 
expedited medical evaluations, referrals, laboratory services, 
electrocardiograms , pulmonary function tests (PFT), exercise tolerance 
testing (ETT), and Naval Aerospace Medicine Institute (NAMI) submissions.  
Expedited consults, ETT, and PFT are defined as performed and completed 
within seven business days from the time of the consult or order.  These 
consults and tests will not require pre -appointment COVID-19 testing if 
patient has met the Centers for Disease Control and Prevention recovery 
criteria and it is less than 90 days from date of symptom onset.

3. NAMI will conduct submission review within two business working days for 
completed submissions that require NAMI duty disposition per reference (c).  
Contact NAMI when submitting a post-COVID-19 evaluation to fast track the 
review.  NAMI Physical Expedite Request Email:  
usn.pensacola.navmedotcnamefl.list.nami-physqualtech(@)mail.mil.  Aerospace 
Medicine providers who conduct a return to flight duty status evaluation on 
aircrew who had a symptomatic case of COVID-19 shall report each evaluation 
to the aircrew's Type Commander Force Surgeon, Marine Air Wing Surgeon, or if 
outside those administrative controls to the Bureau of Medicine and Surgery, 
Branch Head, Aerospace Medicine Programs.

4.  All commands with personnel who are required to have a Class 1 or Class 2 
Aeromedical Examination to be in a Special Duty Flight Status, with personnel 
who perform Aeromedical Examinations, and with personnel who provide medical 
care for naval aircrew will execute and distribute this policy.

5.  Per reference (c), this ALNAV applies to all civilian and uniformed 
military Navy and Marine Corps personnel required to meet Class 1 and Class 2 
aeromedical physical standards to continue in their Special Duty Flight 
Status.

6.  The primary point of contact for this message is CDR Roy Allen Hoffman, 
roy.a.hoffman.mil(@)mail.mil, (703) 681-9323.

7.  Released by the Honorable Kenneth J. Braithwaite, Secretary of the Navy.

BT
#0001
NNNN
UNCLASSIFIED//